Extending Jak2V617F and MplW515 mutation analysis to single hematopoietic colonies and B and T lymphocytes

被引:53
作者
Pardanani, Animesh
Lasho, Terra L.
Finke, Christy
Mesa, Ruben A.
Hogan, William J.
Ketterling, Rhett P.
Gilliland, Dwight Gary
Tefferi, Ayalew
机构
[1] Mayo Clin, Div Hematol, Rochester, MN 55905 USA
[2] Mayo Clin, Div Lab Med & Pathol, Rochester, MN 55905 USA
[3] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA 02115 USA
[5] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA
关键词
hematopoietic progenitor cells; human CD34 and CD43 cells; colony formation; JAK kinase; myelopoiesis;
D O I
10.1634/stemcells.2007-0175
中图分类号
Q813 [细胞工程];
学科分类号
摘要
JAK2V617F and MPLW515L/K are myeloproliferative disorder (MPD)-associated mutations. We genotyped 552 individual hematopoietic colonies obtained by CD34+ cell culture from 16 affected patients (13 JAK2V617F and 3 MPLW515L/K) to determine (a) the proportion of colonies harboring a particular mutation in the presence or absence of cytokines, (b) the lineage distribution of endogenous colonies for each mutation, and (c) the differences (if any) in the pattern of mutation among the various MPDs, as established by genotyping of individual colonies. Genotyping analysis revealed cohabitation of mutation-negative and mutation-positive endogenous colonies in polycythemia vera as well as other MPDs. Culture of progenitor cells harboring MPLW515L/K yielded virtually no endogenous erythroid colonies in contrast to JAK2V617F-harboring progenitor cells. The mutation pattern (i.e., relative distribution of homozygous, heterozygous, or wild-type colonies) was not a distinguishing feature among the MPDs, and MPLW515 mutations were detected in B and/or T lymphocytes in all three patients tested. These observations suggest that clonal myelopoiesis antedates acquisition of JAK2V617F or MPLW515L/K mutations and that the latter is acquired in a lympho-myeloid progenitor cell.
引用
收藏
页码:2358 / 2362
页数:5
相关论文
共 28 条
[1]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[2]   Genetic and clinical implications of the Val617Phe JAK2 mutation in 72 families with myeloproliferative disorders [J].
Bellanne-Chantelot, Christine ;
Chaumarel, Isabelle ;
Labopin, Myriarn ;
Bellanger, Florence ;
Barbu, Veronique ;
De Toma, Claudia ;
Delhommeau, Frangois ;
Casadevall, Nicole ;
Vainchenker, William ;
Thomas, Gilles ;
Najman, Albert .
BLOOD, 2006, 108 (01) :346-352
[3]   Characterization of murine JAK2V617F-positive myeloproliferative disease [J].
Bumm, Thomas G. P. ;
Elsea, Collin ;
Corbin, Amie S. ;
Loriaux, Marc ;
Sherbenou, Daniel ;
Wood, Lisa ;
Deininger, Jutta ;
Silver, Richard T. ;
Druker, Brian J. ;
Deininger, Michael W. N. .
CANCER RESEARCH, 2006, 66 (23) :11156-11165
[4]   The JAK2V617F mutation is acquired secondary to the predisposing alteration in familial polycythaemia vera [J].
Cario, H ;
Goerttler, PS ;
Steimle, C ;
Levine, RL ;
Pahl, HL .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (05) :800-801
[5]   Highly sensitive fluorescence in situ hybridization method to detect double BCR/ABL fusion and monitor response to therapy in chronic myeloid leukemia [J].
Dewald, GW ;
Wyatt, WA ;
Juneau, AL ;
Carlson, RO ;
Zinsmeister, AR ;
Jalal, SM ;
Spurbeck, JL ;
Silver, RT .
BLOOD, 1998, 91 (09) :3357-3365
[6]  
Dobo I, 2004, HAEMATOLOGICA, V89, P1207
[7]   Interleukin-10 inhibits erythropoietin-independent growth of erythroid bursts in patients with polycythemia vera [J].
Geissler, K ;
Öhler, L ;
Födinger, M ;
Kabrna, E ;
Kollars, M ;
Skoupy, S ;
Lechner, K .
BLOOD, 1998, 92 (06) :1967-1972
[8]   A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera [J].
James, C ;
Ugo, V ;
Le Couédic, JP ;
Staerk, J ;
Delhommeau, F ;
Lacout, C ;
Garçon, L ;
Raslova, H ;
Berger, R ;
Bennaceur-Griscelli, A ;
Villeval, JL ;
Constantinescu, SN ;
Casadevall, N ;
Vainchenker, W .
NATURE, 2005, 434 (7037) :1144-1148
[9]   The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation [J].
Jamieson, CHM ;
Gotlib, J ;
Durocher, JA ;
Chao, MP ;
Mariappan, MR ;
Lay, M ;
Jones, C ;
Zehnder, JL ;
Lilleberg, SL ;
Weissman, IL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (16) :6224-6229
[10]   Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disorders [J].
Kiladjian, JJ ;
Elkassar, N ;
Cassinat, B ;
Hetet, G ;
Giraudier, S ;
Balitrand, N ;
Conejero, C ;
Briere, J ;
Fenaux, P ;
Chomienne, C ;
Grandchamp, B .
LEUKEMIA, 2006, 20 (06) :1181-1183